Beijing Continent Pharmaceutical Co, Ltd.
29
10
10
8
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 29 trials
100.0%
+13.5% vs industry average
24%
7 trials in Phase 3/4
0%
0 of 8 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (29)
A Study of Hydronidone Capsules in Patients With Chronic Hepatitis B Virus-Related Liver Fibrosis
Role: lead
Pirfenidone Capsules in the Treatment of Radiation-induced Lung Injury With or Without Immune Pneumonia
Role: lead
A Study to Evaluate the Safety of Hydronidone Capsules in Patients With Liver Fibrosis
Role: lead
A Clinical Trial Evaluating the Safety of Hydronidone Capsules in Patients With Hepatic Fibrosis and Liver Cirrhosis
Role: lead
QTc Assessment in a Single-Dose Study of Hydronidone Capsules
Role: lead
[¹⁴C] Hydronidone Mass Balance Study
Role: lead
Preliminary Human Trials of F230 Tablets
Role: lead
A Phase IIIc Clinical Study to Evaluate the Long-term Treatment of Hydronidone Capsules for Liver Fibrosis in Patients With Chronic Hepatitis B.
Role: lead
Study of Hydroxynidone Capsules in Patients With Hepatic Impairment and Matched Healthy Controls
Role: lead
A Trial of Hydroxynidone Capsules in Single-dose Administration for Patients With Renal Insufficiency
Role: lead
Drug-Drug Interaction Study Between Hydronidone and Entecavir, Tenofovir Disoproxil Fumarate, Tenofovir Alafenamide, and Tenofovir Amibufenamide
Role: lead
The Phase Ⅰd Clinical Trial of Hydronidone Capsules
Role: lead
Efficacy and Safety of Pirfenidone Capsules in the Treatment of Pneumoconiosis
Role: lead
F573 for Injection for the Treatment of Liver Injury/Failure
Role: lead
PirfenidoneVsPlacebo as Prophylaxis Against Acute Radiation-induced Lung Injury Following HFRT in Breast Cancer Patients
Role: collaborator
Hydronidone Capsules in Long-term Treatment in Patients With Chronic Viral Hepatitis B Liver Fibrosis
Role: lead
A Study About Safety and Efficacy of Pirfenidone to Treat Grade 2 or Grade3 Radiation-induced Lung Injury.
Role: lead
Hydronidone for the Treatment of Liver Fibrosis Associated with Chronic Viral Hepatitis B Phase 3 Trial.
Role: lead
Pirfenidone Treat Myocardial Fibrosis After Acute Myocardial Infarction
Role: collaborator
F573 Ia Clinical Trial
Role: lead